Security key
23284F105
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (CTMX)
CUSIP: 23284F105
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock, $0.00001 par value per share ("Common Stock")
- Shares outstanding
- 217,079,600
- Total 13F shares
- 32,393,313
- Share change
- -1,726,664
- Total reported value
- $41,785,804
- Put/Call ratio
- 9.9%
- Price per share
- $1.29
- Number of holders
- 61
- Value change
- -$2,418,556
- Number of buys
- 13
- Number of sells
- 32
Report period
Q3 2023
Institutions
61
Top holders
10
CTMX full security history
Newer quarter: Q4 2023
Previous quarter: Q2 2023
CytomX Therapeutics, Inc. SEC filings
CytomX Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 23284F105
Recent filing periods:
Top shareholders of CTMX - CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
3%
|
6,600,000
|
$11,352,000 | — | 30 Jun 2023 | |
| BVF INC/IL |
13F
|
Company |
3%
|
6,595,801
|
$11,344,778 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.3%
|
4,902,943
|
$8,433,062 | — | 30 Jun 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.2%
|
2,653,576
|
$4,562,000 | — | 30 Jun 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.75%
|
1,621,409
|
$2,788,823 | — | 30 Jun 2023 | |
| Laurion Capital Management LP |
13F
|
Company |
0.55%
|
1,188,225
|
$2,043,747 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.53%
|
1,147,816
|
$1,974,243 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.52%
|
1,122,400
|
$1,931,000 | — | 30 Jun 2023 | |
| Bronte Capital Management Pty Ltd. |
13F
|
Company |
0.43%
|
925,245
|
$1,591,421 | — | 30 Jun 2023 | |
| FMR LLC |
13F
|
Company |
0.34%
|
727,380
|
$1,251,092 | — | 30 Jun 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.31%
|
674,501
|
$1,160,142 | — | 30 Jun 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.31%
|
668,032
|
$1,149,015 | — | 30 Jun 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.3%
|
649,298
|
$1,116,793 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
644,087
|
$1,107,829 | — | 30 Jun 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.16%
|
344,169
|
$592,000 | — | 30 Jun 2023 | |
| Formidable Asset Management, LLC |
13F
|
Company |
0.15%
|
318,111
|
$547,000 | — | 30 Jun 2023 | |
| Tidal Investments LLC |
13F
|
Company |
0.15%
|
318,111
|
$547,000 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.12%
|
267,476
|
$460,059 | — | 30 Jun 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.12%
|
259,965
|
$447,140 | — | 30 Jun 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
238,024
|
$409,401 | — | 30 Jun 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.11%
|
229,400
|
$394,568 | — | 30 Jun 2023 | |
| Clearline Capital LP |
13F
|
Company |
0.09%
|
196,583
|
$338,122 | — | 30 Jun 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.08%
|
184,494
|
$317,330 | — | 30 Jun 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.07%
|
156,040
|
$268,389 | — | 30 Jun 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.06%
|
138,447
|
$238,129 | — | 30 Jun 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.06%
|
130,460
|
$224,391 | — | 30 Jun 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
119,614
|
$205,736 | — | 30 Jun 2023 | |
| Congress Park Capital LLC |
13F
|
Company |
0.05%
|
106,150
|
$182,578 | — | 30 Jun 2023 | |
| LPL Financial LLC |
13F
|
Company |
0.05%
|
98,265
|
$169,016 | — | 30 Jun 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
90,242
|
$155,216 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
84,276
|
$144,955 | — | 30 Jun 2023 | |
| CORNERCAP INVESTMENT COUNSEL INC |
13F
|
Company |
0.04%
|
82,415
|
$141,754 | — | 30 Jun 2023 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.03%
|
73,179
|
$126,451 | — | 30 Jun 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.02%
|
53,705
|
$92,370 | — | 30 Jun 2023 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.02%
|
53,243
|
$92,000 | — | 30 Jun 2023 | |
| Forefront Analytics, LLC |
13F
|
Company |
0.02%
|
49,596
|
$85,306 | — | 30 Jun 2023 | |
| Amy C. Peterson |
3/4/5
|
EVP, Chief Development Officer |
—
class O/S missing
|
58,433
|
$80,678 | — | 16 Mar 2023 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.02%
|
44,730
|
$76,936 | — | 30 Jun 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
35,865
|
$61,688 | — | 30 Jun 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.02%
|
34,084
|
$58,624 | — | 30 Jun 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
31,866
|
$54,810 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
31,262
|
$53,770 | — | 30 Jun 2023 | |
| Carlos Campoy |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
38,224
|
$52,776 | — | 16 Mar 2023 | |
| Alison L. Hannah |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
31,898
|
$44,042 | — | 19 Jul 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.01%
|
24,817
|
$42,685 | — | 30 Jun 2023 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.01%
|
24,700
|
$42,484 | — | 30 Jun 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
21,440
|
$36,877 | — | 30 Jun 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.01%
|
19,458
|
$33,468 | — | 30 Jun 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
19,364
|
$33,306 | — | 30 Jun 2023 | |
| WestHill Financial Advisors, Inc. |
13F
|
Company |
0.01%
|
17,082
|
$29,381 | — | 30 Jun 2023 |
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (CTMX) as of Q3 2023
As of 30 Sep 2023,
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (CTMX) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,393,313 shares.
The largest 10 holders included
BVF INC/IL, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, Laurion Capital Management LP, BlackRock Inc., JACOBS LEVY EQUITY MANAGEMENT, INC, RENAISSANCE TECHNOLOGIES LLC, Bronte Capital Management Pty Ltd., and FMR LLC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
66
Q3 2023 holders
61
Holder diff
-5
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.